Double-blind, Placebo-controlled Crossover Evaluation of the Effect of PUR003 on Subjects With Asthma.

Trial Profile

Double-blind, Placebo-controlled Crossover Evaluation of the Effect of PUR003 on Subjects With Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2013

At a glance

  • Drugs PUR 003 (Primary)
  • Indications Allergic asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 21 May 2012 Results were presented at the International Conference of the American Thoracic Society (ATS) in May 2012.
    • 21 Nov 2011 Actual end date changed from May 2011 to Oct 2011 as reported by ClinicalTrials.gov.
    • 28 Mar 2011 Planned end date changed from 1 Jun 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top